IMAX/$IMAX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About IMAX
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
- Ticker
- $IMAX
- Sector
- Consumer Discretionary
- Primary listing
- NYSE
- Employees
- 679
- Headquarters
- Mississauga, Canada
- Website
- www.imax.com
IMAX Metrics
BasicAdvanced
$2.8B
69.45
$0.73
0.40
-
Price and volume
Market cap
$2.8B
Beta
0.4
52-week high
$57.73
52-week low
$31.27
Average daily volume
983K
Financial strength
Current ratio
4.264
Quick ratio
3.796
Long term debt to equity
0.627
Total debt to equity
0.627
Interest coverage (TTM)
12.69%
Profitability
EBITDA (TTM)
138.217
Gross margin (TTM)
59.73%
Net profit margin (TTM)
9.84%
Operating margin (TTM)
22.84%
Effective tax rate (TTM)
24.40%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
6.65%
Return on equity (TTM)
11.02%
Valuation
Price to earnings (TTM)
69.446
Price to revenue (TTM)
6.59
Price to book
7.8
Price to tangible book (TTM)
9.9
Price to free cash flow (TTM)
27.419
Free cash flow yield (TTM)
3.65%
Free cash flow per share (TTM)
1.846
Growth
Revenue change (TTM)
14.79%
Earnings per share change (TTM)
21.99%
3-year revenue growth (CAGR)
5.76%
10-year revenue growth (CAGR)
0.71%
3-year earnings per share growth (CAGR)
107.66%
10-year earnings per share growth (CAGR)
0.51%
What the Analysts think about IMAX
Analyst ratings (Buy, Hold, Sell) for IMAX stock.
Analyst projections of the future price of IMAX stock.
Bulls say / Bears say
IMAX generated $728 million worldwide over summer 2026, up 73% on its previous record, and captured 5.8% of global summer box office on just over 1,800 screens. This shows the format can attract a disproportionate share of demand. (IMAX Corporation)
Second-quarter revenue rose 12% year on year to $103 million and diluted EPS grew 35% to $0.27, while net income margin expanded to 15.5%. Box-office strength is therefore translating into higher profits. (SEC)
IMAX installed 38 systems in Q2, its highest second-quarter total in a decade, and ended June with 421 systems in backlog and 9% year-on-year growth in its network outside China. This offers scope to expand the platform beyond the success of any single film. (SEC)
Greater China box office fell 62% year on year in Q1 2026, contributing to lower quarterly revenue despite growth outside China. This shows how release timing and comparisons in a key market can make results uneven. (The Motley Fool, IMAX Corporation)
US cinema admissions from 1 January to 16 August were 30% below the same period in 2019, despite higher nominal box-office receipts. A smaller pool of moviegoers remains a structural risk for a business tied to theatrical releases. (The New York Times)
A 5 October market analysis said IMAX shares had risen more than 30% in three months and put the consensus target near $55, only modestly above the share price at the time. That leaves room for a reset if strong film results and premium-format growth fail to meet expectations. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 22 Oct 2026.
IMAX Financial Performance
Revenues and expenses
IMAX Earnings Performance
Company profitability
Upcoming events
No upcoming events
IMAX News
AllArticlesVideos
Funds containing IMAX
Fund name | Fund size | $IMAX weighting |
|---|---|---|
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.09% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.09% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.08% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.08% |
iShares MSCI World Small Cap£WLDS | $9B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.